Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mylan, Biocon help market generic insulin drugs
Yahoo/AP
Thursday, February 14, 2013 - 10:18am
tags:
Biocon, Mylan, generics, diabetes, insulin, Lantus, Humalog, Novolog
The Best Dividend in Big Pharma
Motley Fool
Thursday, February 14, 2013 - 10:06am
tags:
Sanofi, dividends
Pfizer to Novartis Seen Gaining as Drought Ends: Health
Bloomberg
Thursday, February 14, 2013 - 10:05am
tags:
Pfizer, Novartis, Sanofi
Teva warns could face legal costs of $2.07 bln
Reuters
Thursday, February 14, 2013 - 10:04am
tags:
Protonix, Pfizer, generics, Teva
Merck To Pay $688 Million To Shareholders For Delaying Vytorin Results
Forbes
Thursday, February 14, 2013 - 9:57am
tags:
Vytorin, Merck, settlements, ENHANCE
Cumberland Pharmaceuticals: A Rare Value Stock In The Drug Industry
Seeking Alpha
Wednesday, February 13, 2013 - 11:34am
tags:
Cumberland, Perrigo
Feds still zealous about off-label marketing, DoJ official says
Fierce Pharma
Wednesday, February 13, 2013 - 11:08am
tags:
whistleblowers, off-label, DOJ
Novartis Marrow Drug Fails to Win U.K. Agency Backing
Bloomberg
Wednesday, February 13, 2013 - 11:04am
tags:
Novartis, UK, Jakavi
MannKind Earnings Call Insights: Partnership Status and AFREZZA
Wall St. Cheat Sheet
Wednesday, February 13, 2013 - 11:03am
tags:
MannKind, Afrezza, earnings
Acorda Therapeutics Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Wednesday, February 13, 2013 - 11:02am
tags:
Acorda Therapeutics, earnings
[video]1 Upcoming Catalyst for Ziopharm
Motley Fool
Wednesday, February 13, 2013 - 11:01am
tags:
Ziopharm, palifosfamide
Albany Molecular Research Misses Where it Counts
Motley Fool
Wednesday, February 13, 2013 - 11:00am
tags:
Albany Molecular Research
Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug
TheStreet.com
Wednesday, February 13, 2013 - 11:00am
tags:
Peregrine Pharmaceuticals, bavituximab, pancreatic cancer
CSL First-Half Profit Jumps on Blood-Based Therapies
Bloomberg
Wednesday, February 13, 2013 - 10:59am
tags:
CSL, earnings
After failed trials, J&J pivots to early-stage Alzheimer's
Reuters
Wednesday, February 13, 2013 - 10:44am
tags:
Alzheimer's disease, JNJ, bapineuzumab
This Obesity Bet Just Became More Attractive
Motley Fool
Wednesday, February 13, 2013 - 10:43am
tags:
obesity, Vivus, Pfizer, Qsymia, Arena Pharmaceuticals
How Much Will Pfizer's New Drugs Contribute To Future Revenue?
Seeking Alpha
Wednesday, February 13, 2013 - 10:41am
tags:
Pfizer
Merck's Crash of a Titan
Motley Fool
Wednesday, February 13, 2013 - 10:29am
tags:
Merck, Singulair
Merck Cuts First-Quarter Forecast on Venezuela Currency
Bloomberg
Wednesday, February 13, 2013 - 10:28am
tags:
Merck, Venezuela
Keryx Pharmaceuticals: In Or Out?
Seeking Alpha
Wednesday, February 13, 2013 - 10:27am
tags:
Keryx, Zerenex, renal disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.